JamesG.HermanMDFRCP(C)

Breast Cancer, Central Nervous System Cancer, Gastrointestinal Cancer, Urologic Cancer

MEDICAL DIRECTOR/PRESIDENT MMORA,PC/CHIEF RADIATION ONCOLOGY SPARROW CANCER CENTER

Dr. Herman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1215 E Michigan Ave
Lansing, MI 48912
Phone+1 269-567-9835

Fax+1 269-567-9841

I am a board certified medical and radiation oncologist,practising oncology at Sparrow Cancer Center.
My interests are breast cancer and gynaecologic cancers.
I also have an expertise in testicular cancer.

Hurley Medical Center/Michigan State UniversityInternship, Transitional Year, 1973 - 1974
University Saskatchewan Royal HospitalClass of 1973

PubMed

842 citations
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer
Hiromu Suzuki, D. Neil Watkins, Kam Wing Jair, Kornel E. Schuebel, Sanford D. Markowitz
Nature Genetics. 2004-03-14
4823 citations
The cancer genome atlas pan-cancer analysis project
John N. Weinstein, Eric A. Collisson, Gordon B. Mills, Kenna R. Mills Shaw, Brad Ozenberger
Nature Genetics. 2013-10-01
116 citations
SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Yan Jia, Yunsheng Yang, Shuang Liu, James G. Herman, Fengmin Lu
Epigenetics. 2010-11-16

P1: Epigenetic Staging And Therapy For Lung CancersNational Cancer Institute2009–2012
CHFR Methylation For Predicting Taxane Sensitivity In Lung And Esophageal CancerNational Cancer Institute2008–2011
CHFR Methylation For Predicting Taxane Sensitivity In Lung And Esophageal CancerNational Cancer Institute2007
Molecular Detection Of Breast CancerNational Cancer Institute2000–2002